Trial Profile

A PK/PD clinical trail of otenaproxesul in post-operative pain indication

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 21 Mar 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Otenaproxesul (Primary)
Indications Postoperative pain
Focus Pharmacodynamics; Pharmacokinetics
Sponsors Antibe Therapeutics

Most Recent Events

21 Mar 2024 According to an Antibe Therapeutics media release,the company announced a moderated poster presentation of data from otenaproxesul s recent pharmacokinetic pharmacodynamic (PK PD) study. The poster will be presented at the 49th Annual Regional Anesthesiology and Acute Pain Medicine Meeting
30 Jun 2022 Status changed from planning to completed, according to an Antibe Therapeutics media release.
11 Nov 2021 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com